Weight loss induced by glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and dual
glucagon‐like peptide‐1 receptor (GLP‐1R)/glucose‐dependent insulinotropic polypeptide …

The rapid and widespread clinical adoption of highly effective incretin‐mimetic drugs (IMDs),
particularly semaglutide and tirzepatide, for the treatment of obesity has outpaced the …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …

The science of cardiac rehabilitation and the secondary prevention of cardiovascular
disease has progressed substantially since the most recent American Heart Association and …

Coronary artery disease (CAD) is highly prevalent in older adults, yet its management
remains challenging. Treatment choices are made complex by the frailty burden of older …

The triad of vascular impairment, muscle atrophy, and cognitive decline represents critical
age-related conditions that significantly impact health. Vascular impairment disrupts blood …

Objective: To elucidate the bidirectional correlation of sarcopenia with coronary heart
disease (CHD), as well as to investigate the mediating role of cardiometabolic factors and …

Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1
receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes …

The biological clock system is an intrinsic timekee** device that integrates internal
physiology and external cues. Maintaining a healthy biological clock system is crucial for life …

BACKGROUND: Sarcopenia and hypertension are independently associated with worse
cardiovascular disease (CVD) risk and survival. While individuals with sarcopenia may …